• Email Us: [email protected]
  • Contact Us: +1 718 874 1545
  • Skip to main content
  • Skip to primary sidebar

Medical Market Report

  • Home
  • All Reports
  • About Us
  • Contact Us

Markets in Q3: Bears in the China shop

September 30, 2021 by David Barret Leave a Comment

September 30, 2021

By Marc Jones and Julien Ponthus

LONDON (Reuters) – Some of the heaviest falls ever seen in China’s markets, huge energy price rises and the clearest signs yet that central banks are starting to turn off the money taps have all hit world markets over the last quarter.

A regulatory crackdown in China has wiped a trillion dollars off its markets and sent giants such as Alibaba tumbling 30% in their worst quarter on record, while property firm Evergrande, one of the world’s biggest high-yield debt issuers, is on the brink of default.

World stocks meanwhile are headed for their first quarter of losses since COVID-19 began to take its toll early last year, bonds have had a shaky September amid taper talk, and the safe-haven dollar is gunning for its best year since 2015.

At the same time, inflation is gathering pace on the back of rising commodity and shipping costs. Natural gas is up nearly 60% since July and 120% this year, coffee is up 25% for the second quarter in a row and freight costs have risen another 40%.

Emmanuel Cau, head of European equities at Barclays, reckons markets are pricing the end of the ‘Goldilocks’ scenario – when growth and inflation are neither too high nor too low – so investors should be aware of the bears.

“The end of Q3 is somewhat a foretaste of what’s to come with central banks starting to shift policies,” Cau said, noting a “brutal regime change” as investors switch from sectors such as tech into so-called value shares such as banks and energy.

“One also needs to take into account that Chinese growth will be weaker moving forward.”

For a graphic on Global markets in 2021 and Q3:

https://ift.tt/2Y3MNOg

CHINA SMASHED

The biggest drama was in Chinese markets where a crackdown on tech, digital and for-profit education firms deepened, followed by the Evergrande meltdown.

It all added up to a near trillion-dollar slide in Chinese equities, a 70% slump in Evergrande shares and a 14% bashing for anyone invested in high-yield Chinese corporate debt.

China’s worries meant MSCI’s emerging equity index dropped almost 10% after five quarters of gains and its underperformance versus Wall Street has been an eye-watering 30 percentage points.

“This has been one of the most value-destructive periods for Chinese equity markets in history,” said William Mileham at Swiss-based asset manager Mirabaud, adding that it felt like the regulatory pressures might not end.

For a graphic on China’s stocks slammed by clampdowns:

https://ift.tt/3D25zoq

The rising dollar also complicated life for other emerging markets, with the Chilean, Brazilian and Peruvian currencies down 7% to 9% over the quarter.

Turkey’s lira lost more ground after a recent surprise interest rate cut, remaining the year’s worst performer.

For a graphic on China’s high market market pounded by Evergrande default worries:

https://ift.tt/3oqvlib

STOCKS SPLICED

World stock markets are ending the quarter in disorderly fashion, with MSCI’s global index down around 1%, its first quarterly first loss since early 2020.

Pandemic plays Zoom and Peloton have lost about a third of their value, but vaccine makers Moderna and Pfizer are up 60% and 11% respectively, and aeroplane engine maker Rolls Royce has soared over 40%.

For many investors, September will likely be remembered as the end of a financial fairy tale when fiscal and monetary stimulus combined with buoyant growth and moderate inflation relentlessly kept pushing stock prices to record highs.

Rising yields have already prompted a brutal rotation within equity portfolios as managers typically dumped growth and tech stocks for cheaper shares in the banking and oil and gas industries.

The Nasdaq came off 2% over the quarter but lost about 4.5% in September as sell-side analysts encouraged their clients to go for “value” and cut risk out of FAANGS. Even Amazon has lost ground.

“It is a very, very challenging time to build a portfolio”, said Roland Kaloyan, who heads Societe Generale’s European equity strategy.

“At the same time you want to have exposure to rising yields, hedge against rising yields and hedge your portfolio against slowing growth in China”.

For a graphic on MSCI Value vs Growth and Bund yields:

https://ift.tt/3kVF2Dl

BONDS – NO TIME TO BUY

Bond markets, after a huge July rally, tumbled in September after hawkish turns from the U.S. Federal Reserve and the Bank of England, giving global government bond buyers a rare loss of 1%.

Clear third-quarter winners were inflation-linked bonds in the euro area and Britain, with returns of some 3% each, according to ICE BofA indexes. These securities are benefiting from fears that inflation spurred by supply-chain disruptions and labour shortages will be less transitory than flagged..

Globally there have now been more than 50 separate interest rate hikes this year, led by emerging market inflation hotspots like Brazil and Russia.

On credit markets, away from China’s turbulence, the lowest-rated “junk” euro corporate debt — at Triple C or lower — have returned around 1.4% as companies continue to recover from the pandemic.

For a graphic on Global FX year to date:

https://ift.tt/39PioGc

(Reporting by Marc Jones and Julien Ponthus; Additional reporting by Sujata Rao, Danilo Masoni and Yoruk Bahceli; Editing by Hugh Lawson)

Source Link Markets in Q3: Bears in the China shop

David Barret
David Barret

Related posts:

  1. Australia’s treasurer says economy must diversify from China reliance
  2. China Evergrande bonds suspended as prices slump
  3. At unfinished Evergrande apartments in central China, buyers seek answers
  4. U.S. sanctions several Hong Kong-based Chinese entities over Iran -website

Filed Under: News

Reader Interactions

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Primary Sidebar

  • The US’s Surprisingly Recent Plan To Nuke The Moon In Search Of “Negative Mass”
  • 14,400-Year-Old Paw Prints Are World’s Oldest Evidence Of Humans Living Alongside Domesticated Dogs
  • The Tribe That Has Lived Deep Within The Grand Canyon For Over 1,000 Years
  • Finger Monkeys: The Smallest Monkeys In The World Are Tiny, Chatty, And Adorable
  • Atmospheric River Brings North America’s Driest Place 25 Percent Of Its Yearly Rainfall In A Single Day
  • These Extinct Ice Age Giant Ground Sloths Were Fans Of “Cannonball Fruit”, Something We Still Eat Today
  • Last Year’s Global Aurora-Sparking “Superstorm” Squashed Earth’s Plasmasphere To A Fifth Its Usual Size
  • Theia – The Giant Impactor That Formed The Moon – Assembled Closer To The Sun Than Earth Is Now
  • Testosterone And Body Odor May Quietly Influence How People Perceive The Social Status Of Men
  • There Have Been At Least 50 Incidents Of Spiders Capturing And Eating Bats (That We Know Of)
  • A “Very Old, Undisturbed Structure” May Have Been Discovered Beyond The Orbit Of Neptune, 43 AU From The Sun
  • NASA Finally Reveals Comet 3I/ATLAS Images From 8 Missions, Including First From Another Planet’s Surface
  • 360 Million Years Ago, Cleveland Was Home To A Giant Predatory Fish Unlike Anything Alive Today
  • Under RFK Jr, CDC Turns Against Scientific Consensus On Autism And Vaccines, Incorrectly Claiming Lack Of Evidence
  • Megalodon VS T. Rex: Who Had The Biggest Teeth?
  • The 100 Riskiest Decisions You’ll Likely Ever Make
  • Funky-Nosed “Pinocchio” Chameleons Get A Boost As They Turn Out To Be Multiple Species
  • The Leech Craze: The Medical Fad That Nearly Eradicated A Species
  • Unusual Rock Found By NASA’s Perseverance Rover Likely “Formed Elsewhere In The Solar System”
  • Where Does The “H” In Jesus H. Christ Come From? This Bible Scholar Explains All
  • Business
  • Health
  • News
  • Science
  • Technology
  • +1 718 874 1545
  • +91 78878 22626
  • [email protected]
Office Address
Prudour Pvt. Ltd. 420 Lexington Avenue Suite 300 New York City, NY 10170.

Powered by Prudour Network

Copyrights © 2025 · Medical Market Report. All Rights Reserved.

Go to mobile version